• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TP53基因Arg72Pro多态性与甲状腺癌风险之间的关联。

Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.

作者信息

Wang Fang, Wang Peng, Wang Bin, Fu Zheng-Ju, Yuan Ying, Yan Sheng-Li, Zhao Wen-Juan, Wang Yan-Gang

机构信息

Department of Endocrinology, The Affiliated Hospital of Medical College, Qingdao University, 16 Jiangsu Road, Qingdao, 266003, China.

出版信息

Tumour Biol. 2014 Mar;35(3):2723-8. doi: 10.1007/s13277-013-1359-x. Epub 2013 Dec 28.

DOI:10.1007/s13277-013-1359-x
PMID:24375191
Abstract

TP53 Arg72Pro polymorphism has been proposed to have some effects on host's susceptibility to cancer. Several studies were published to assess the association between TP53 Arg72Pro polymorphism and thyroid carcinoma, but they reported controversial results. We performed a systemic review and meta-analysis to assess the association between TP53 Arg72Pro polymorphism and thyroid carcinoma. Odds ratio (OR) with 95% confidence interval (95% CI) was used to assess the association. Fourteen individual studies with 3,483 subjects were finally included into the meta-analysis. Overall, there was an obvious association between TP53 Arg72Pro polymorphism and thyroid carcinoma under the recessive model (ProPro vs. ArgArg/ArgPro, OR = 2.02, 95% CI 1.13 to 3.62, P = 0.02). Subgroup analysis by race showed that TP53 Arg72Pro polymorphism was associated with thyroid carcinoma in Caucasians (ProPro vs. ArgArg/ArgPro, OR = 2.31, 95% CI 1.08 to 4.93, P = 0.03). Subgroup analysis by histological type showed that TP53 Arg72Pro polymorphism was not associated with a risk of different types of thyroid carcinoma. In summary, the meta-analysis suggests that TP53 Arg72Pro polymorphism is associated with thyroid carcinoma risk in Caucasians. Besides, more studies with large sample size are needed to further assess the associations above.

摘要

TP53基因第72位密码子精氨酸(Arg)突变为脯氨酸(Pro)的多态性被认为对宿主患癌易感性有一定影响。已有多项研究发表,旨在评估TP53基因Arg72Pro多态性与甲状腺癌之间的关联,但结果存在争议。我们进行了一项系统综述和荟萃分析,以评估TP53基因Arg72Pro多态性与甲状腺癌之间的关联。采用比值比(OR)及95%置信区间(95%CI)评估两者的关联强度。最终,14项涉及3483名受试者的独立研究被纳入荟萃分析。总体而言,在隐性模型下(ProPro与ArgArg/ArgPro相比),TP53基因Arg72Pro多态性与甲状腺癌之间存在显著关联(OR = 2.02,95%CI为1.13至3.62,P = 0.02)。按种族进行的亚组分析显示,在白种人中TP53基因Arg72Pro多态性与甲状腺癌有关(ProPro与ArgArg/ArgPro相比;OR = 2.31,95%CI为1.08至4.93,P = 0.03)。按组织学类型进行亚组分析显示,TP53基因Arg72Pro多态性与不同类型甲状腺癌的发病风险无关。综上所述, 荟萃分析表明TP53基因Arg72Pro多态性与白种人患甲状腺癌的风险有关, 此外, 需要更多大样本研究来进一步评估上述关联关系

相似文献

1
Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.TP53基因Arg72Pro多态性与甲状腺癌风险之间的关联。
Tumour Biol. 2014 Mar;35(3):2723-8. doi: 10.1007/s13277-013-1359-x. Epub 2013 Dec 28.
2
Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.p53基因Arg72Pro多态性与甲状腺癌风险的关联:一项荟萃分析。
Tumour Biol. 2014 Jan;35(1):561-5. doi: 10.1007/s13277-013-1078-3. Epub 2013 Sep 15.
3
Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.TP53基因Arg72Pro多态性与胶质瘤风险关联的定量评估。
Tumour Biol. 2014 Jan;35(1):747-51. doi: 10.1007/s13277-013-1101-8. Epub 2013 Sep 18.
4
Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.TP53 Arg72Pro 多态性与膀胱癌风险关联的定量评估。
Mol Biol Rep. 2013 Mar;40(3):2389-95. doi: 10.1007/s11033-012-2319-z. Epub 2012 Nov 27.
5
Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.TP53基因Arg72Pro多态性与肝细胞癌风险的关联:一项荟萃分析。
Asian Pac J Cancer Prev. 2012;13(9):4305-9. doi: 10.7314/apjcp.2012.13.9.4305.
6
Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.基于病例对照研究的TP53基因Arg72Pro多态性与子宫内膜异位症风险关联的Meta分析。
Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:1-7. doi: 10.1016/j.ejogrb.2015.03.015. Epub 2015 Mar 14.
7
Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.TP53基因Arg72Pro多态性与白血病风险的关联:14项病例对照研究的荟萃分析
Sci Rep. 2016 Apr 7;6:24097. doi: 10.1038/srep24097.
8
TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.TP53 Arg72Pro 多态性与食管癌风险相关:一项荟萃分析。
World J Gastroenterol. 2011 Mar 7;17(9):1227-33. doi: 10.3748/wjg.v17.i9.1227.
9
Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis.P53 Arg72Pro 与消化道癌症发展的相关性:荟萃分析。
Arch Med Res. 2011 Jan;42(1):60-9. doi: 10.1016/j.arcmed.2011.01.008.
10
Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis.p53基因Arg72Pro多态性评估及其与癌症风险的关联:一项人类基因流行病学(HuGE)综述与荟萃分析
Genet Res (Camb). 2015 Apr 17;97:e7. doi: 10.1017/S0016672315000075.

引用本文的文献

1
Identifying Thyroid Carcinoma-Related Genes by Integrating GWAS and eQTL Data.整合全基因组关联研究(GWAS)和表达定量性状位点(eQTL)数据以鉴定甲状腺癌相关基因
Front Cell Dev Biol. 2021 Feb 4;9:645275. doi: 10.3389/fcell.2021.645275. eCollection 2021.
2
Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer.TP53基因密码子72多态性与口腔癌易感性关联的Meta分析结果
Front Physiol. 2018 Aug 2;9:1014. doi: 10.3389/fphys.2018.01014. eCollection 2018.
3
Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.

本文引用的文献

1
Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk.解毒基因是遗传性髓样甲状腺癌风险的重要调节剂。
Clin Endocrinol (Oxf). 2013 Aug;79(2):288-93. doi: 10.1111/cen.12136.
2
Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.证据表明,解毒基因的多态性调节散发型甲状腺髓样癌的易感性。
Eur J Endocrinol. 2012 Feb;166(2):241-5. doi: 10.1530/EJE-11-0843. Epub 2011 Nov 2.
3
Molecular genetics and diagnosis of thyroid cancer.甲状腺癌的分子遗传学与诊断。
miR-211-5p的过表达通过下调SOX11来抑制甲状腺肿瘤细胞的增殖、迁移和侵袭。
J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22293. Epub 2017 Jul 13.
4
Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.TP53基因密码子72多态性与急性髓系白血病易感性的关联:基于荟萃分析的证据
Med Sci Monit. 2015 Oct 9;21:3048-53. doi: 10.12659/MSM.894625.
5
Regulation of MET-mediated proliferation of thyroid carcinoma cells by miR-449b.miR-449b对MET介导的甲状腺癌细胞增殖的调控
Tumour Biol. 2015 Nov;36(11):8653-60. doi: 10.1007/s13277-015-3619-4. Epub 2015 Jun 6.
6
Thyroid carcinoma cells produce PLGF to enhance metastasis.甲状腺癌细胞产生胎盘生长因子以增强转移能力。
Tumour Biol. 2015 Nov;36(11):8601-7. doi: 10.1007/s13277-015-3548-2. Epub 2015 Jun 4.
7
TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis.TP53基因多态性可能导致患桥本甲状腺炎的遗传易感性。
J Endocrinol Invest. 2015 Nov;38(11):1175-82. doi: 10.1007/s40618-015-0292-9. Epub 2015 May 3.
Nat Rev Endocrinol. 2011 Aug 30;7(10):569-80. doi: 10.1038/nrendo.2011.142.
4
Multikinase inhibitors: a new option for the treatment of thyroid cancer.多激酶抑制剂:甲状腺癌治疗的新选择。
Nat Rev Endocrinol. 2011 Aug 23;7(10):617-24. doi: 10.1038/nrendo.2011.141.
5
Depicting the role of TP53 in hepatocellular carcinoma progression.描绘 TP53 在肝细胞癌进展中的作用。
J Hepatol. 2011 Sep;55(3):724-725. doi: 10.1016/j.jhep.2011.03.018. Epub 2011 May 14.
6
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
7
Thyroid cancer in 2010: a roadmap for targeted therapies.2010年的甲状腺癌:靶向治疗路线图。
Nat Rev Endocrinol. 2011 Feb;7(2):65-7. doi: 10.1038/nrendo.2010.232.
8
p53 and its mutants in tumor cell migration and invasion.p53 及其突变体在肿瘤细胞迁移和侵袭中的作用。
J Cell Biol. 2011 Jan 24;192(2):209-18. doi: 10.1083/jcb.201009059.
9
Involvement of CYP1A1, GST, 72TP53 polymorphisms in the pathogenesis of thyroid nodules.CYP1A1、谷胱甘肽S-转移酶(GST)、72TP53基因多态性与甲状腺结节发病机制的关系。
Genet Mol Res. 2010 Nov 16;9(4):2222-9. doi: 10.4238/vol9-4gmr807.
10
Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies.Arg72Pro TP53 多态性与癌症易感性:302 项病例对照研究的综合荟萃分析。
Int J Cancer. 2011 Aug 15;129(4):920-30. doi: 10.1002/ijc.25710. Epub 2010 Dec 2.